Muñoz N, Bosch X, Kaldor J M
Unit of Field & Intervention Studies, International Agency for Research on Cancer, Lyon, France.
Br J Cancer. 1988 Jan;57(1):1-5. doi: 10.1038/bjc.1988.1.
The human papillomavirus has emerged over the past decade as the leading candidate to be the sexually transmitted aetiological factor in cervical cancer. Although it appears that papillomavirus types 16 and 18 are associated with a higher risk of advanced cervical neoplasia, most of the evidence comes from studies which do not satisfy basic epidemiological requirements, and are therefore difficult to interpret. The most significant problems are the small sample size, potentially biased selection of study subjects, the difficulties in cytologically distinguishing precancerous lesions from papilloma infection of the cervix, the unknown specificity and sensitivity of the various hybridisation methods for determining papillomavirus infection status, and the statistical analyses and presentation of results. On the basis of the existing studies, one is forced to conclude that, while experimental data suggest an oncogenic potential for HPV, the epidemiological evidence implicating it as a cause of cervical neoplasia is still rather limited.
在过去十年中,人乳头瘤病毒已成为宫颈癌性传播病因的首要候选因素。虽然16型和18型乳头瘤病毒似乎与晚期宫颈肿瘤形成的较高风险相关,但大多数证据来自不符合基本流行病学要求的研究,因此难以解释。最显著的问题是样本量小、研究对象的选择可能存在偏差、在细胞学上难以区分癌前病变与宫颈乳头瘤感染、用于确定乳头瘤病毒感染状况的各种杂交方法的特异性和敏感性未知,以及结果的统计分析和呈现。基于现有研究,人们不得不得出这样的结论:虽然实验数据表明人乳头瘤病毒具有致癌潜力,但将其作为宫颈肿瘤形成原因的流行病学证据仍然相当有限。